blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1448585

EP1448585 - ANTISENSE MODULATION OF INHIBITOR-KAPPA B KINASE-GAMMA EXPRESSION [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  15.04.2005
Database last updated on 16.11.2024
Most recent event   Tooltip13.11.2009Change - representativepublished on 16.12.2009  [2009/51]
Applicant(s)For all designated states
Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad, CA 92010 / US
[N/P]
Former [2004/35]For all designated states
ISIS PHARMACEUTICALS, INC.
2292 Faraday Avenue
Carlsbad, CA 92008 / US
Inventor(s)01 / MONIA, Brett, P.
2306 Casa Hermosa Court
Encinitas, CA 92024 / US
02 / WYATT, Jacqueline, R.
1065 Hymettus Avenue
Encinitas, CA 92024 / US
 [2004/35]
Representative(s)Hallybone, Huw George, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2009/51]Hallybone, Huw George, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Former [2004/35]Hallybone, Huw George, et al
Carpmaels and Ransford, 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date02784022.203.10.2002
[2004/35]
WO2002US31809
Priority number, dateUS2001097260706.10.2001         Original published format: US 972607
[2004/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03031576
Date:17.04.2003
Language:EN
[2003/16]
Type: A2 Application without search report 
No.:EP1448585
Date:25.08.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 17.04.2003 takes the place of the publication of the European patent application.
[2004/35]
Search report(s)International search report - published on:US12.09.2003
ClassificationIPC:C07H21/04, A61K31/70
[2004/35]
CPC:
C12N15/1137 (EP,US); C12Y207/1101 (EP,US); A61K38/00 (EP,US);
C12N2310/315 (EP,US); C12N2310/321 (EP,US); C12N2310/3341 (EP,US);
C12N2310/341 (EP,US); C12N2310/346 (EP,US); Y02P20/582 (EP,US) (-)
C-Set:
C12N2310/321, C12N2310/3525 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/35]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ANTISENSE-MODULATION DER EXPRESSION VON INHIBITOR-KAPPA-B-KINASE-GAMMA[2004/35]
English:ANTISENSE MODULATION OF INHIBITOR-KAPPA B KINASE-GAMMA EXPRESSION[2004/35]
French:MODULATION ANTISENS DE L'EXPRESSION DE L'INHIBITEUR KAPPA B KINASE-GAMMA[2004/35]
Entry into regional phase05.05.2004National basic fee paid 
05.05.2004Search fee paid 
05.05.2004Designation fee(s) paid 
05.05.2004Examination fee paid 
Examination procedure05.05.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
05.05.2004Examination requested  [2004/35]
09.07.2004Amendment by applicant (claims and/or description)
04.04.2005Application withdrawn by applicant  [2005/22]
Fees paidRenewal fee
05.05.2004Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US6114517  (MONIA BRETT P [US], et al);
 [X]  - KRAPPMANN ET AL, "The Ikb Kinase (IKK) complex is tripartite and contains IKKgamma but not IKAP as a regular component", THE JOURNAL OF BIOLOGICAL CHEMISTRY, USA, (20000922), vol. 275, no. 38, pages 29779 - 29787, XP002963212

DOI:   http://dx.doi.org/10.1074/jbc.M003902200
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.